Boston Scientific Corp (BSX)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 39,395,000 | 38,078,000 | 37,108,000 | 36,669,000 | 35,136,000 | 34,043,000 | 33,601,000 | 32,892,000 | 32,470,000 | 31,948,000 | 32,190,000 | 32,337,000 | 32,230,000 | 31,877,000 | 31,168,000 | 30,900,000 | 30,778,000 | 30,845,000 | 30,823,000 | 30,113,000 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $39,395,000K
= 0.00
The debt-to-assets ratio for Boston Scientific Corp has consistently remained at 0.00 for the past several quarters, indicating that the company has not reported any financial debt on its balance sheet relative to its total assets. This suggests that Boston Scientific has been operating with minimal or no debt financing during the analyzed period, which can be a positive indicator of financial strength and stability. A low or zero debt-to-assets ratio typically signifies that the company is not highly leveraged and may have a lower risk of financial distress or default. However, it is important to assess this ratio in conjunction with other financial metrics to get a holistic view of the company's financial health and leverage position.
Peer comparison
Dec 31, 2024